Fascioscapulohumeral Muscular Dystrophy clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Showing trials for
Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)
Sorry, not currently recruiting here
A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Adult Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
Irvine, California and other locations
Last updated: